Japan drugmaker reports user death

By Agence France-Presse

Mar 27, 2024 12:23 am

TOKYO: A major Japanese drugmaker said on Tuesday it was investigating one death from kidney dysfunction potentially linked to health supplements recalled last week by the firm.

It comes a day after the drugmaker, Kobayashi Pharmaceutical, said it was aware of 26 cases of people being hospitalized in relation to the prescription-free supplements.

Already have an active account? Log in here to continue reading.
Or
Subscribe to the Premium Subscription plan to access this subscriber-exclusive article.

Related Articles

Indian magnate Adani charged in US

China advisers call for steady 2025 growth goal

Nvidia posts $19-B quarterly profit

Google ordered to sell Chrome browser

Boeing can't afford another mistake – CEO

Hyundai unveils big electric SUV

US auto execs further temper EV push